Steven Canfield, MD, of UTHealth Houston shares the results of his recent study looking at the real-world utilization of active surveillance among men with localized prostate cancer who were tested with the genomic prostate score assay.
Dr. Canfield presented his results at the 2024 European Association of Urology Congress.